Literature DB >> 9083010

The p120-v-Abl protein interacts with E2F-1 and regulates E2F-1 transcriptional activity.

M C Birchenall-Roberts1, Y D Yoo, D C Bertolette, K H Lee, J M Turley, O S Bang, F W Ruscetti, S J Kim.   

Abstract

The E2F family of transcription factors regulates cell cycle progression, and deregulated expression of E2F-1 can lead to neoplastic transformation. In myeloid cells, introduction and expression of the Abelson leukemia virus causes growth factor independence. Here, the p120 v-Abl protein activates E2F-1-mediated transcription through a physical interaction with the E2F-1 transcription factor. BCR-Abl and c-Abl also stimulate E2F-1-mediated transcription. Our results suggest a new mechanism by which v-Abl leads to factor-independent myeloid cell proliferation: the activation of E2F-1-mediated transcription.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9083010     DOI: 10.1074/jbc.272.14.8905

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  6 in total

1.  hsa-mir183/EGR1-mediated regulation of E2F1 is required for CML stem/progenitor cell survival.

Authors:  Francesca Pellicano; Laura Park; Lisa E M Hopcroft; Mansi M Shah; Lorna Jackson; Mary T Scott; Cassie J Clarke; Amy Sinclair; Sheela A Abraham; Alan Hair; G Vignir Helgason; Mark Aspinall-O'Dea; Ravi Bhatia; Gustavo Leone; Kamil R Kranc; Anthony D Whetton; Tessa L Holyoake
Journal:  Blood       Date:  2018-02-05       Impact factor: 22.113

2.  Second generation tyrosine kinase inhibitors prevent disease progression in high-risk (high CIP2A) chronic myeloid leukaemia patients.

Authors:  C M Lucas; R J Harris; A K Holcroft; L J Scott; N Carmell; E McDonald; F Polydoros; R E Clark
Journal:  Leukemia       Date:  2015-03-13       Impact factor: 11.528

3.  Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis.

Authors:  Anna M Eiring; Paolo Neviani; Ramasamy Santhanam; Joshua J Oaks; Ji Suk Chang; Mario Notari; William Willis; Carlo Gambacorti-Passerini; Stefano Volinia; Guido Marcucci; Michael A Caligiuri; Gustavo W Leone; Danilo Perrotti
Journal:  Blood       Date:  2007-10-09       Impact factor: 22.113

4.  The last CTD repeat of the mammalian RNA polymerase II large subunit is important for its stability.

Authors:  Rob D Chapman; Benoit Palancade; Andreas Lang; Olivier Bensaude; Dirk Eick
Journal:  Nucleic Acids Res       Date:  2004-01-02       Impact factor: 16.971

5.  BCR/ABL1 and BCR are under the transcriptional control of the MYC oncogene.

Authors:  Nitesh Sharma; Vera Magistroni; Rocco Piazza; Stefania Citterio; Caterina Mezzatesta; Praveen Khandelwal; Alessandra Pirola; Carlo Gambacorti-Passerini
Journal:  Mol Cancer       Date:  2015-07-16       Impact factor: 27.401

6.  STAT3 is required for the gp130-mediated full activation of the c-myc gene.

Authors:  N Kiuchi; K Nakajima; M Ichiba; T Fukada; M Narimatsu; K Mizuno; M Hibi; T Hirano
Journal:  J Exp Med       Date:  1999-01-04       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.